A comprehensive analysis conducted by public health experts at Novartis Romania reveals that Romanian patients may wait, on ...

XOANACYL is an oral therapy designed to address critical challenges in CKD, including Iron deficiency and hyperphosphatemia Averoa submitted XOANACYL for UK approval via MHRA’s International ...